Buffer Preparation Market Industry Trends and Global Forecasts to 2035: Market Strengthens With 60+ Systems and 70+ Service Providers – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Buffer Preparation Market Industry Trends and Global Forecasts to 2035: Distribution by Scale of Operation, Type of System Component, Type of Buffer Formulation, Type of Molecule, Type of Compatible Biologic, Type of Buffer Packaging, Geographical Regions and Leading Players” report has been added to ResearchAndMarkets.com’s offering. The buffer preparation market size is currently … [Read more…]

Joi + Blokes Acquires HerMD, Creating One of the Nation’s Largest Virtual Care Platforms for Women

NASHVILLE, Tenn.–(BUSINESS WIRE)–Joi + Blokes, a national virtual clinic supporting women’s health across menopause, longevity, and optimal healthspan, today announced its acquisition of HerMD, a nationally recognized organization advancing evidence-based care in menopause, sexual health, and hormonal wellness. The acquisition unites two category-defining platforms to form one of the nation’s most comprehensive virtual specialty care … [Read more…]

Valo Health Appoints Rita Kale as Chief Financial Officer

LEXINGTON, Mass.–(BUSINESS WIRE)–Valo Health, Inc. (“Valo”), a company pioneering the use of human data and AI to accelerate drug discovery and development, today announced the appointment of Rita Kale as Chief Financial Officer (CFO). Rita brings more than two decades of global finance leadership in biopharma, diagnostics, and technology-enabled healthcare. “We are proud to welcome … [Read more…]

European Enterprises Strive for AI Innovation and Compliance, ISG Says

Airbus, Dassault Systèmes, Thales, L’Oréal, Schneider Electric, Air Liquide, Shell, Adecco, Crédit Agricole, Bureau Veritas, Cigref, BNP Paribas and UEFA to join ISG AI Impact Summit PARIS–(BUSINESS WIRE)–#AI–Organizations in Europe are prioritizing adaptable business partnerships with strong governance frameworks to help them leverage AI and meet the data governance and compliance requirements set forth under … [Read more…]

Pre-filled Syringe Presentation of BYOOVIZ®, Samsung Bioepis’ Biosimilar to Lucentis (Ranibizumab), Gains European Approval

European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopts positive opinion for BYOOVIZ® (ranibizumab) pre-filled syringe (PFS) PFS presentation to become available in Europe in the second quarter of 2026, after the full transition of commercial rights from Biogen back to Samsung Bioepis in January 2026 INCHEON, Korea–(BUSINESS WIRE)–#amd–Samsung Bioepis Co., … [Read more…]

Bayer Welcomes Solicitor General Support for U.S. Supreme Court Review

Company continues to advance multi-pronged strategy to significantly contain the litigation by the end of 2026 LEVERKUSEN, Germany–(BUSINESS WIRE)–Bayer is pleased the Solicitor General supports U. S. Supreme Court review of the petition for a writ of certiorari in the Durnell case and agrees with the company’s arguments on preemption. The company believes that the … [Read more…]

Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners

VANCOUVER, British Columbia & DALLAS–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” or the “Company”), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced that Alpha Cognition will participate in an upcoming virtual fireside chat hosted by Boris Peaker of Titan Partners. The discussion will focus on commercialization efforts and research … [Read more…]

PSMA-Targeted Therapy & Radiodiagnostics Competitor Analysis Report 2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Competitor Analysis: PSMA-Targeted Therapy & Radiodiagnostics” report has been added to ResearchAndMarkets.com’s offering. This competitive intelligence report about PSMA-Targeted Therapies & Radiodiagnostics provides a competitor evaluation in the field of product candidates in research and development targeting prostate-specific membrane antigen (PSMA). The report lists PSMA-targeted R&D programs by R&D phase in a tabular … [Read more…]

Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced a merger with MindWave Innovations Inc, uniting Apimeds’ late-stage, non-opioid pain-management biologic portfolio with MindWave’s AI-driven Bitcoin treasury, digital asset yield generation, and $NILA-powered ecosystem. The combined company integrates high-growth biotechnology and institutional digital-treasury capabilities, with the merger supported by a simultaneous PIPE of up to $100 … [Read more…]

Novocure Appoints Company President Frank Leonard as Chief Executive Officer

BAAR, Switzerland–(BUSINESS WIRE)–$NVCR–Novocure (NASDAQ: NVCR) today announced the appointment of Frank Leonard as Chief Executive Officer (CEO), effective immediately. Mr. Leonard previously served as President of Novocure and succeeds Ashley Cordova who has resigned from the company. “During his more than 15-year career at Novocure, Frank has led many of our global business operations developing … [Read more…]